Pro Share Advisors LLC Aeglea Bio Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.5 - $2.66 $6,340 - $33,728	-12,680 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$1.87 - $4.77 $5,780 - $14,744	-3,091 Reduced 19.6%	12,680 $29,000
Q4 2021 Feb 08, 2022	BUY	$3.5 - $8.42 $395 - $951	113 Added 0.72%	15,771 $75,000
Q3 2021 Nov 12, 2021	SELL	$6.03 - $7.95 $21,919 - $28,898	-3,635 Reduced 18.84%	15,658 $124,000
Q2 2021 Aug 13, 2021	BUY	$6.32 - $8.38 $3,766 - $4,994	596 Added 3.19%	19,293 $134,000
Q1 2021 May 14, 2021	BUY	$6.76 - $8.57 $8,767 - $11,115	1,297 Added 7.45%	18,697 $148,000
Q4 2020 Feb 09, 2021	BUY	$7.02 - $9.83 $35,542 - $49,769	5,063 Added 41.04%	17,400 $137,000
Q3 2020 Nov 13, 2020	SELL	$6.51 - $9.33 $3,215 - $4,609	-494 Reduced 3.85%	12,337 $87,000
Q2 2020 Aug 03, 2020	BUY	$4.01 - $11.04 $51,452 - $141,654	12,831 New	12,831 $119,000
Q4 2019 Feb 12, 2020	SELL	$7.23 - $8.55 $78,091 - $92,348	-10,801 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$6.42 - $9.0 $2,240 - $3,141	349 Added 3.34%	10,801 $83,000
Q2 2019 Aug 13, 2019	SELL	$6.1 - $8.78 $5,819 - $8,376	-954 Reduced 8.36%	10,452 $72,000
Q1 2019 May 15, 2019	BUY	$7.6 - $9.4 $86,685 - $107,216	11,406 New	11,406 $92,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.